June 8, 2017
Mike Derkacz named CEO of Braeburn Pharmaceuticals
Braeburn Pharmaceuticals names Dallas native Michael M. Derkacz as president and CEO. Most recently he was senior vice president and head of global central nervous system (CNS) and pain therapeutic areas for Teva Pharmaceuticals (Teva). He is an alumni of University of Texas at Arlington.